Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › IL-1 antagonist formulations

IL-1 antagonist formulations

US Patent 7572893 · Granted Aug 11, 2009

Estimated economic value: $20,275,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Devices and methods for overfilling drug containers2025
VEGF antagonist formulations suitable for intravitreal administration2025
Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodie2024
Process for reducing subvisible particles in a pharmaceutical formulation2024
Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodie2024
Devices and methods for overfilling drug containers2024
Citrate buffered VEGF antagonist formulations2023
VEGF antagonist formulations suitable for intravitreal administration2023
Stabilized formulations containing anti-PCSK9 antibodies2023
Devices and methods for overfilling drug containers2023
Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodie2021
VEGF antagonist formulations suitable for intravitreal administration2021